Northern Trust Corp Regeneron Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,054,829 shares of REGN stock, worth $752 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,054,829
Previous 918,645 14.82%
Holding current value
$752 Million
Previous $966 Million 22.19%
% of portfolio
0.11%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$701.85 - $1046.91 $95.6 Million - $143 Million
136,184 Added 14.82%
1,054,829 $751 Million
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $49.2 Million - $57.8 Million
-48,081 Reduced 4.97%
918,645 $966 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $21.8 Million - $26.5 Million
-24,739 Reduced 2.5%
966,726 $1.02 Billion
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $49.6 Million - $54.6 Million
-54,943 Reduced 5.25%
991,465 $954 Million
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $16.1 Million - $18.3 Million
-20,802 Reduced 1.95%
1,046,408 $919 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $23.8 Million - $29 Million
34,326 Added 3.32%
1,067,210 $878 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $85.2 Million - $101 Million
-121,689 Reduced 10.54%
1,032,884 $742 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $6.42 Million - $7.81 Million
-9,439 Reduced 0.81%
1,154,573 $949 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $17.5 Million - $19 Million
-24,785 Reduced 2.08%
1,164,012 $840 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $5.95 Million - $7.51 Million
-10,365 Reduced 0.86%
1,188,797 $819 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $1.07 Million - $1.44 Million
-1,952 Reduced 0.16%
1,199,162 $709 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $1.32 Million - $1.54 Million
-2,212 Reduced 0.18%
1,201,114 $839 Million
Q4 2021

Feb 08, 2022
BUY
$543.48 - $670.97 $1.79 Million - $2.21 Million
3,291 Added 0.27%
1,203,326 $760 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $22.1 Million - $26.2 Million
38,532 Added 3.32%
1,200,035 $726 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $7.37 Million - $8.71 Million
-15,589 Reduced 1.32%
1,161,503 $649 Million
Q1 2021

May 12, 2021
SELL
$446.73 - $548.2 $29.4 Million - $36.1 Million
-65,883 Reduced 5.3%
1,177,092 $557 Million
Q4 2020

Feb 11, 2021
SELL
$478.3 - $607.98 $20.9 Million - $26.6 Million
-43,727 Reduced 3.4%
1,242,975 $600 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $33.5 Million - $40.5 Million
61,531 Added 5.02%
1,286,702 $720 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $130 Million - $170 Million
264,126 Added 27.48%
1,225,171 $764 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $4.86 Million - $7.14 Million
14,449 Added 1.53%
961,045 $469 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $1.31 Million - $1.8 Million
4,771 Added 0.51%
946,596 $355 Million
Q3 2019

Nov 13, 2019
SELL
$273.46 - $318.39 $10 Million - $11.7 Million
-36,693 Reduced 3.75%
941,825 $261 Million
Q2 2019

Aug 13, 2019
BUY
$299.6 - $414.82 $1.66 Million - $2.29 Million
5,530 Added 0.57%
978,518 $306 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $7.52 Million - $8.89 Million
20,218 Added 2.12%
972,988 $400 Million
Q4 2018

Feb 12, 2019
BUY
$335.82 - $403.04 $7.55 Million - $9.06 Million
22,468 Added 2.42%
952,770 $356 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $1.38 Million - $1.61 Million
-3,943 Reduced 0.42%
930,302 $376 Million
Q2 2018

Sep 18, 2018
SELL
$284.6 - $344.99 $1.99 Million - $2.41 Million
-6,983 Reduced 0.74%
934,245 $322 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $7.09 Million - $8.6 Million
24,914 Added 2.72%
941,228 $325 Million
Q1 2018

May 09, 2018
SELL
$315.82 - $393.78 $5.97 Million - $7.44 Million
-18,895 Reduced 2.02%
916,314 $316 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $8.16 Million - $10.7 Million
-22,751 Reduced 2.37%
935,209 $352 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $413 Million - $483 Million
957,960
957,960 $428 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email